BioDelivery Sciences Stock Price - BDSI

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
BioDelivery Sciences International Inc BDSI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.095 1.84% 5.255 5.31 5.17 5.20 5.16 12:32:42
Bid Price Ask Price Spread Spread % News
5.26 5.27 0.01 0.19% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,007 638,964 $ 5.24 $ 3,350,577 663,557 2.80 - 5.3732
Last Trade Time Type Quantity Stock Price Currency
12:32:57 10 $ 5.265 USD

BioDelivery Sciences Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 468.65M 89.52M $ -33.87M -0.71 -25.87 84.13M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 7.00 6.00%

more financials information »

BioDelivery Sciences News

Loading Messages....

Latest BDSI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BDSI Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week4.755.314.715.03271M0.50510.63%
1 Month4.595.314.154.7405729k0.66514.49%
3 Months3.755.313.464.4432611k1.50540.13%
6 Months4.685.313.464.4635776k0.57512.29%
1 Year3.625.37322.84.4231771k1.63545.17%
3 Years2.485.37321.53.2875607k2.775111.90%
5 Years16.9618.331.55.1517795k-11.705-69.02%

BioDelivery Sciences Description

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its marketed products and those in development address serious and debilitating conditions such as chronic pain, breakthrough cancer pain, and opioid dependence.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.